News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
170,919 Results
Type
Article (31823)
Company Profile (11)
Press Release (139085)
Multimedia
Podcasts (4)
Webinars (9)
Section
Business (52006)
Career Advice (365)
Deals (3223)
Drug Delivery (8)
Drug Development (23786)
Employer Resources (32)
FDA (3313)
Job Trends (3178)
News (80329)
Policy (4162)
Tag
2024 Biotech Bay Standard (2)
2024 Pharm Country Standard (1)
2026 Biotech Bay Standard (1)
Academia (2402)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (19)
Alliances (10849)
ALS (27)
Alzheimer's disease (521)
Antibody-drug conjugate (ADC) (21)
Approvals (3338)
Artificial intelligence (52)
Autoimmune disease (1)
Automation (4)
Bankruptcy (18)
Best Places to Work (2670)
BIOSECURE Act (3)
Biosimilars (8)
Biotechnology (13)
Bladder cancer (19)
Brain cancer (8)
Breast cancer (85)
Cancer (593)
Cardiovascular disease (39)
Career advice (339)
Career pathing (9)
CAR-T (42)
Cell therapy (110)
Cervical cancer (6)
Clinical research (18470)
Collaboration (163)
Compensation (8)
Complete response letters (1)
COVID-19 (1173)
CRISPR (12)
C-suite (145)
Cystic fibrosis (23)
Data (707)
Decentralized trials (1)
Denatured (3)
Depression (6)
Diabetes (54)
Diagnostics (1652)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (23)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (19)
Earnings (6290)
Editorial (5)
Employer branding (2)
Employer resources (29)
Events (17540)
Executive appointments (452)
FDA (3551)
Featured Employer (3)
Frontotemporal dementia (4)
Funding (199)
Gene editing (31)
Generative AI (3)
Gene therapy (74)
GLP-1 (124)
Government (942)
Guidances (3)
Healthcare (5047)
Huntington's disease (2)
IgA nephropathy (7)
Immunology and inflammation (10)
Indications (9)
Infectious disease (1206)
Inflammatory bowel disease (41)
Inflation Reduction Act (1)
Influenza (16)
Intellectual property (16)
Interviews (41)
IPO (1457)
IRA (6)
Job creations (574)
Job search strategy (316)
Kidney cancer (5)
Labor market (6)
Layoffs (32)
Leadership (3)
Legal (684)
Liver cancer (21)
Lung cancer (80)
Lymphoma (46)
Machine learning (2)
Management (9)
Manufacturing (38)
MASH (24)
Medical device (3031)
Medtech (3032)
Mergers & acquisitions (1813)
Metabolic disorders (117)
Multiple sclerosis (18)
NASH (5)
Neurodegenerative disease (24)
Neuropsychiatric disorders (1)
Neuroscience (641)
NextGen: Class of 2025 (1798)
Non-profit (1702)
Northern California (628)
Now hiring (4)
Obesity (39)
Opinion (29)
Ovarian cancer (30)
Pain (15)
Pancreatic cancer (26)
Parkinson's disease (38)
Partnered (4)
Patents (39)
Patient recruitment (33)
Peanut (12)
People (32278)
Phase I (5870)
Phase II (8465)
Phase III (5619)
Pipeline (181)
Policy (21)
Postmarket research (955)
Preclinical (3049)
Press Release (25)
Prostate cancer (27)
Psychedelics (8)
Radiopharmaceuticals (66)
Rare diseases (87)
Real estate (1276)
Recruiting (15)
Regulatory (2956)
Reports (3)
Research institute (1349)
Resumes & cover letters (23)
Rett syndrome (2)
RNA editing (1)
RSV (1)
Schizophrenia (9)
Series A (30)
Series B (19)
Sickle cell disease (16)
Southern California (484)
Spinal muscular atrophy (38)
Sponsored (6)
Startups (1105)
Stomach cancer (1)
Tariffs (3)
The Weekly (1)
United States (4756)
Vaccines (201)
Venture capitalists (1)
Weight loss (22)
Women's health (6)
Worklife (2)
Date
Today (31)
Last 7 days (150)
Last 30 days (568)
Last 365 days (6980)
2025 (2031)
2024 (7451)
2023 (9227)
2022 (11488)
2021 (13226)
2020 (12767)
2019 (12131)
2018 (9004)
2017 (8691)
2016 (8880)
2015 (10208)
2014 (7798)
2013 (7575)
2012 (7542)
2011 (7544)
2010 (6762)
Location
Africa (264)
Alabama (11)
Alaska (3)
Arizona (38)
Arkansas (6)
Asia (10390)
Australia (2607)
California (1309)
Canada (410)
China (96)
Colorado (59)
Connecticut (63)
Delaware (27)
Europe (27527)
Florida (159)
Georgia (48)
Idaho (12)
Illinois (121)
India (3)
Indiana (61)
Iowa (2)
Japan (48)
Kansas (13)
Kentucky (4)
Louisiana (1)
Maine (13)
Maryland (144)
Massachusetts (838)
Michigan (38)
Minnesota (67)
Mississippi (1)
Missouri (20)
Montana (6)
Nebraska (4)
Nevada (11)
New Hampshire (8)
New Jersey (372)
New Mexico (8)
New York (385)
North Carolina (259)
North Dakota (2)
Northern California (628)
Ohio (66)
Oklahoma (5)
Oregon (9)
Pennsylvania (255)
Puerto Rico (1)
Rhode Island (11)
South America (289)
South Carolina (3)
Southern California (484)
Tennessee (25)
Texas (191)
Utah (41)
Virginia (34)
Washington D.C. (18)
Washington State (135)
West Virginia (1)
Wisconsin (10)
170,919 Results for "temple university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Temple Street Biotech Initiates Groundbreaking Therapeutic Antibody for Alzheimer’s Disease
Temple Street Biotech is proud to announce the initiation of a pioneering therapeutic antibody targeting prion protein for the treatment of Alzheimer’s disease.
May 21, 2024
·
2 min read
Policy
JUVÉDERM® VOLUMA® XC For Temple Hollows Receives U.S. FDA Approval
Allergan Aesthetics, an AbbVie company, announced the U.S. FDA approval of JUVÉDERM® VOLUMA® XC for injection in the temple region to improve moderate to severe temple hollowing in adults over the age of 21.
March 5, 2024
·
10 min read
Temple Health Joins U.S. Study of Artificial Intelligence Diagnostic System for DVT Detection
Temple Health is partnering with ThinkSono, a UK-based AI company, to study a new artificial intelligence -powered ultrasound technology that enables more rapid and portable diagnosis of deep vein thrombosis.
February 13, 2024
·
2 min read
Three Medical Journals Investigate Temple University for Potential Data Manipulation
Three medical journals have launched investigations into publications by researchers at Temple University to determine if there was data manipulation.
September 14, 2022
·
4 min read
·
Mark Terry
Pharm Country
Temple University Hospital Adopts Masimo Centroid™
Masimo and Temple Health announced that Temple University Hospital, a 722-bed academic medical center located in Philadelphia, is expanding its use of Masimo technologies with Centroid™, an advanced wireless patient position, orientation, activity, and respiration rate sensor, at 100 beds across its ICU units.
February 7, 2022
·
13 min read
Genetown
Temple Therapeutics Reveals Breakthrough Findings on Ovarian Cancer at AACR 2023
Temple Therapeutics presented new in vitro and in vivo data on TTX335o, the first drug candidate from the company’s platform that won the Eurostar Eureka peer-reviewed grant process in 2019 for ovarian cancer.
May 8, 2023
·
6 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Genetown
Ground-Breaking Human Trial by Temple Therapeutics Solves 187-Year-Old Surgical Mystery of Eradicating Painful Adhesions
Temple Therapeutics released the publication of its Phase 2 trial for the first pharmaceutical known as TTX333 which shows the complete prevention of post-surgical adhesions in 93.3% of patients undergoing gynecological surgery.
June 5, 2023
·
3 min read
Biotech Beach
Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives
Masimo, a leading global provider of medical technology and automation solutions, and Temple Health, Philadelphia’s 979-bed academic health system, announced that they are entering into a strategic innovation collaboration.
March 7, 2023
·
11 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
1 of 17,092
Next
